Archaeosomes composed of total polar [17,24] or semi-synthetic [25] archaeal lipid vesicles represent a robust method for inducing tumor protective CTL responses as they can recruit and activate DCs in vivo in mouse models, and deliver cargo antigen to the MHC class I processing machinery causing CD8+ T cell activation [22]. The gene discussed is CD8A; the disease is neoplasm.